Table 1.

Patient characteristics of the non-rejector group and the rejector group.

	Non-rejectors n = 22	Rejectors n = 24
Age, years (s.d.)	44 (13)	40 (14)
Male/female, n	14/8	14/10
Women with previous pregnancies, n	4	6
Total no. of pregnancies, n	10	17
Cold ischaemia time, h (s.d.)	11 (8)	11 (10)
Panel reactivity, %, mean (s.d.)	6 (14)	6 (15)
Pretransplant infection, %:
CMV seropositive	77	79
EBV seropositive	95	100
Pretransplant bloodtransfusion, %	100	100
Type of donor
Post-mortem/living, n	10/12	12/12
Mismatches, n
HLA-A/B, median (range)	2 (0–4)	2 (0–4)
HLA-DR, median (range)	1 (0–2)	1 (0–2)
Total no. MM, median (range)	3 (0–6)	3 (0–6)
Primary renal disease, n
DM	2	0
Vascular	5	3
Glomerular	6	6
Interstitial	4	6
Hereditary	3	5
Unknown	2	4
Type of rejection, Banff, n
Type I		10
Type II		11
Type III		1
Unknown		2

CMV: cytomegalovirus; EBV: Epstein–Barr virus; HLA: human leucocyte antigen; MM: mismatches; DM: Diabetes Mellitus; s.d.: standard deviation.